Literature DB >> 2770454

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures.

M C Pepin1, S Beaulieu, N Barden.   

Abstract

Increased cortisol secretion, caused by hyperactivity of the brain-pituitary-adrenal axis, and non-suppression of cortisol secretion following dexamethasone administration are two characteristics frequently associated with major depression or the depressed phase of bipolar illness. Antidepressants, irrespective of their selective inhibitory actions on the re-uptake of serotonin or of norepinephrine, modify glucocorticoid receptor messenger RNA concentrations in primary cultures of rat hypothalamic or amygdaloid neurons in a biphasic manner, with predominant stimulatory effects. This suggests a mechanism whereby antidepressants, by restoring the sensitivity of the limbic-hypothalamic system to glucocorticoid feedback inhibition, reverse the hyperactivity of the brain-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770454     DOI: 10.1016/0169-328x(89)90031-4

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  17 in total

1.  Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood.

Authors:  Leandro L Valiengo; Márcio G Soeiro-de-Souza; Andrea H Marques; Doris H Moreno; Mário F Juruena; Ana Cristina Andreazza; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Affect Disord       Date:  2012-02-02       Impact factor: 4.839

2.  Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression.

Authors:  Livia A Carvalho; Mario F Juruena; Andrew S Papadopoulos; Lucia Poon; Rob Kerwin; Anthony J Cleare; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2008-03-26       Impact factor: 7.853

3.  A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats.

Authors:  Elizabeth T Nguyen; Joshua Streicher; Sarah Berman; Jody L Caldwell; Valentina Ghisays; Christina M Estrada; Aynara C Wulsin; Matia B Solomon
Journal:  Physiol Behav       Date:  2017-01-14

Review 4.  The glucocorticoid receptor: pivot of depression and of antidepressant treatment?

Authors:  Christoph Anacker; Patricia A Zunszain; Livia A Carvalho; Carmine M Pariante
Journal:  Psychoneuroendocrinology       Date:  2011-04       Impact factor: 4.905

Review 5.  Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system.

Authors:  J P Herman
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

Review 6.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

7.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 8.  Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

Authors:  Nicholas Barden
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

9.  Sex differences in the pituitary-adrenal response following acute antidepressant treatment in sheep.

Authors:  Jillian H Broadbear; Lisa C Hutton; Iain J Clarke; Benedict J Canny
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

Review 10.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.